There exists a major defect in the innate CD8(+) T cells of chronic phase of CML (CML-CP) patients compared to those of healthy subjects or patients in complete remission following TKI treatment (41). This evidence concerns the gene CD8A and chronic myelogenous leukemia, BCR-ABL1 positive.